Skip to main content
SpringerLink
Log in

Zervixkarzinom im Stadium IIIb: Vorteil durch Radiochemotherapie bestätigt

  • Gynäkoonkologie
  • Literatur kompakt
  • Published:
Im Focus Onkologie Aims and scope

Frauen mit Plattenepithelkarzinom der Zervix im FIGO-Stadium IIIb profitieren stärker von einer kombinierten Radiochemotherapie als von einer alleinigen Bestrahlung. Hierfür gibt es neue Evidenz.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Shrivastava S et al. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix — A Randomized Clinical Trial. JAMA Oncol. 2018;4(4):506–13

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Fakultät, Klinik und Poliklinik für Radioonkologie, CyberKnife- und Strahlentherapie, Universität zu Köln, Köln, Deutschland

    Nadine Gharbi

  2. http://www.springermedizin.de

    Sabine Kunze,  Jan Herter &  Simone Marnitz-Schulze

Authors
  1. Nadine Gharbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabine Kunze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan Herter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simone Marnitz-Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadine Gharbi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gharbi, N., Kunze, S., Herter, J. et al. Zervixkarzinom im Stadium IIIb: Vorteil durch Radiochemotherapie bestätigt. Im Focus Onkologie 21, 41–43 (2018). https://doi.org/10.1007/s15015-018-4283-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-018-4283-5

Search

Navigation